Burrows Scott L sold SYRE
June 25, 2026 · Form 4 insider transaction
Burrows Scott L sold 10,000 shares of Spyre Therapeutics, Inc. at $87.14 per share, a transaction worth $871.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.78 to $87.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.; Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.